Basics Kiniksa Pharmaceuticals, Ltd. IPO Date: May 21, 2018 Sector: Healthcare Industry: Biotech Market Cap: $2.65B Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 2.72% Avg Daily Range (30 D): $0.40 | 1.24% Avg Daily Range (90 D): $0.49 | 1.72% Institutional Daily Volume Avg Daily Volume: .29M Avg Daily Volume (30 D): .51M Avg Daily Volume (90 D): .54M Trade Size Avg Trade Size (Sh.): 70 Avg Trade Size (Sh.) (30 D): 50 Avg Trade Size (Sh.) (90 D): 50 Institutional Trades Total Inst.Trades: 1,457 Avg Inst. Trade: $1.7M Avg Inst. Trade (30 D): $1.78M Avg Inst. Trade (90 D): $3.01M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.68M Avg Closing Trade (30 D): $1.98M Avg Closing Trade (90 D): $3.46M Avg Closing Volume: 86.93K     News Jun 5, 2025 @ 11:00 AM Kiniksa Pharmaceuticals Announces Trial Design of ... Source: N/A May 29, 2025 @ 8:01 PM Kiniksa Pharmaceuticals to Present at Upcoming Inv... Source: N/A Mar 14, 2025 @ 9:51 AM 3 No-Brainer Healthcare Stocks to Buy With $1,000 ... Source: Keith Speights Feb 20, 2025 @ 9:01 PM Kiniksa Pharmaceuticals to Report Fourth Quarter a... Source: N/A Jan 14, 2025 @ 6:00 PM Evolving Landscape of Cardiology Segment: Key Mark... Source: Delveinsight Financials   TTM Q2 2025 Q1 2025 Basic EPS $.06 $.24 $.12 Diluted EPS $.04 $.23 $.11 Revenue $ 529.33M $ 156.8M $ 137.79M Gross Profit $ 454.86M $ 138.19M $ 119.92M Net Income / Loss $ 4.79M $ 17.83M $ 8.54M Operating Income / Loss $ 4.48M $ 20.16M $ 13.27M Cost of Revenue $ 74.48M $ 18.6M $ 17.87M Net Cash Flow $ 92.77M $ 34.91M $ -26.45M PE Ratio 913.37